Key result
Mitochondrial cardiomyopathy shows higher cardiac mitochondrial volume density compared to non-MCM.
Why the study?
Definite diagnosis of mitochondrial cardiomyopathy is difficult due to diverse phenotypes and lacking pathological diagnostic criteria, prompting efforts to integrate myocardial pathology into diagnostic criteria.
Does quantitative electron microscopy and immunohistopathological analysis aid in the diagnosis of mitochondrial cardiomyopathy in patients with hypertrophic or restrictive cardiomyopathy?
Observational (n=11)
Does quantitative electron microscopy and immunohistopathological analysis aid in the diagnosis of mitochondrial cardiomyopathy in patients with hypertrophic or restrictive cardiomyopathy?
Quantitative electron microscopy and immunohistopathological analysis of endomyocardial biopsies can aid in the definitive diagnosis of mitochondrial cardiomyopathy.
AIMS: Mitochondrial cardiomyopathy (MCM) is difficult to make a definite diagnosis because of various cardiovascular phenotypes and no diagnostic criteria in the pathology examination. We aim to add myocardial pathology to the diagnostic criteria for mitochondrial respiratory chain disorders. METHODS: Quantitative analysis of mitochondria using electron microscopy and immunohistopathological analysis with respiratory chain enzyme antibodies were performed in 11 patients with hypertrophic or restrictive cardiomyopathy who underwent endomyocardial biopsy for possible MCM . Respiratory chain enzymatic assay in biopsied myocardium and genetic studies were also performed in all the subjects to define MCM. RESULTS: Four patients were diagnosed with MCM according to the recent criteria of mitochondrial respiratory chain disorders. Using electron microscopy with quantitative analysis, the volume density of mitochondria within cardiac muscle cells was significantly increased in the MCM group compared with the non-MCM group (p=0.007). Immunohistopathological results were compatible with the result of the respiratory chain enzymatic assay. CONCLUSIONS: Pathological diagnosis of MCM could be confirmed by a quantitative study of electron microscopy and immunohistopathological analysis using the mitochondrial respiratory chain enzyme subunit antibody.
No takes yet. Share an insight, caveat, or question.
Takeda et al. (2020) conducted an observational in Hypertrophic or restrictive cardiomyopathy with possible mitochondrial cardiomyopathy (n=11). Mitochondrial cardiomyopathy (MCM) vs. Non-MCM was evaluated on Volume density of mitochondria within cardiac muscle cells (p=0.007). The volume density of mitochondria within cardiac muscle cells was significantly increased in the mitochondrial cardiomyopathy group compared with the non-MCM group (p=0.007).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: